What Intrivo Diagnostics does

Intrivo Diagnostics is a digital health infrastructure company founded in 2020 and headquartered in Miami, Florida, that operates the On/Go platform — a fully integrated digital health stack combining AI-driven personalization, connected device integrations, telehealth, care management, e-commerce, and analytics. The company serves two distinct customer sets: consumers via mobile applications (On/Go for COVID-19 test-to-treat, Sniffles for cold/flu symptom tracking with a connected thermometer, and LEAN for weight management with connected devices), and enterprises through white-label or customized platform licensing to healthcare organizations, device makers, insurance companies, providers, government agencies, pharmaceutical companies, and retailers. Underlying technology centers on a proprietary AI Health Concierge operating across text, structured data, image recognition, and audio modalities, supported by integrations with thermometers, smart rings, and scales, and compliant with SOC 2 Type II and HIPAA standards.

The business model blends three revenue streams: one-time consumer product sales (diagnostic kits and connected devices via owned e-commerce and Amazon); recurring subscription-based healthcare services (telehealth, prescription delivery, care management embedded in the apps); and B2B enterprise platform licensing sold through direct enterprise field sales. The go-to-market combines product-led growth through freemium consumer apps (4.8-star rating across 51,000+ reviews) with traditional enterprise sales targeting large healthcare buyers, supported by a demo-booking motion for platform prospects. Scale signals include millions of consumer users served across the On/Go app portfolio and partnerships with federal, state, and local government agencies for public health initiatives.

The company was co-founded by Ron Gutman and Reeve Benaron, both serving as co-CEOs, and currently employs 251–500 people. It has accumulated third-party validation including an ECRI #1 ranking for delightful user experience in healthcare technology, Greater Good Awards, and Fierce 50 Social Impact recognition. The On/Go platform architecture is structured around five interlocking modules — user management, care management, user engagement, care delivery, and lifelong relationships (marketplace and analytics) — positioning Intrivo as a horizontal digital health operating system rather than a single-category point solution. The On/go for Good Foundation extends the brand into social-impact initiatives focused on healthcare accessibility.

Name

Intrivo Diagnostics

Legal name

Intrivo Diagnostics, Inc.

Website

https://intrivo.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

251–500 employees

Short description

Intrivo Diagnostics operates the On/Go digital health platform, integrating AI-powered personalization, connected devices, telehealth, and care management to serve both consumers directly via mobile apps (On/Go, Sniffles, LEAN) and enterprises through white-label platform licensing to healthcare organizations, insurers, providers, governments, and pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Digital Health Platform

NAICS

Medical and Diagnostic Laboratories (62151), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

akta.pro secondary industries

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration) (HLACAPAJ), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Digital health platform
• AI health concierge
• At-home diagnostics
• Telehealth services
• Connected health devices

Headquarters

HQ city

Santa Monica

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Consumer Diagnostics Products: Sale of physical diagnostic products including COVID-19 tests (On/Go), Sniffles (cold/flu testing), and related connected devices through e-commerce channels.
2. Healthcare Services: Telehealth services, prescription delivery, and care management services integrated into the platform.
3. Enterprise Platform Licensing: B2B licensing of On/Go platform capabilities to healthcare enterprises, device makers, insurance companies, providers, and pharmaceuticals for white-label or customized deployment.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Intrivo Diagnostics operates the On/Go Platform, a fully integrated digital health infrastructure that combines an AI-powered health concierge, telehealth, e-commerce, connected device integrations, care management, and analytics. The company sells consumer diagnostic products directly (On/Go COVID-19 tests, Sniffles connected thermometer, LEAN weight management) and licenses the platform to healthcare enterprises, device makers, insurers, providers, governments, pharmaceuticals, and retailers.

Differentiator

Problem solved

Functional benefit

Brands

• On/Go: COVID-19 test to treat solution and connected health platform featuring mobile app for test results, health tracking, and personalized care guidance.
• Sniffles
• LEAN
• On/go for Good Foundation

Products and services

• On/Go Platform

Quantifiable outcome

• 51,000+ user reviews with 4.8 star rating on On/Go mobile app
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Healthcare EnterprisescoreStrategic or Co-development PartnerSince 2020, Intrivo has been working with leading healthcare enterprises including device makers, insurance companies, healthcare providers, pharmaceuticals, and retailers to create meaningful positive change in healthcare through their On/Go platform.
• Government Health AgenciescoreStrategic or Co-development PartnerPartnerships with Federal, state, and local governments for healthcare solutions including COVID-19 testing and public health emergency response initiatives.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Healthvana: Digital health platform focused on patient engagement, HIV/STI care delivery, and lab results delivery to consumers. Comparable as a digital health infrastructure provider with HIPAA compliance and consumer-facing apps.
• iCarbonX: AI-driven digital health platform combining multi-omics, connected devices, and personalized health insights. Comparable as an AI-first platform aggregating device and health data for personalized consumer guidance.

Direct peers

• Cue Health: Connected at-home molecular diagnostics platform with companion app for test results and care guidance. Comparable consumer-grade diagnostic device + digital platform business model, particularly relevant to On/Go COVID-19 and Sniffles.
• Everlywell: Direct-to-consumer at-home diagnostics platform with telehealth follow-through. Highly comparable to Intrivo's On/Go and Sniffles offerings — both sell consumer diagnostic kits paired with digital platforms and clinician services.
• Ro: Consumer digital health platform providing telehealth, pharmacy delivery, diagnostics, and at-home care across multiple verticals (weight loss, men's/women's health). Highly comparable business model and product breadth to Intrivo's platform approach.
• LetsGetChecked: At-home diagnostics and virtual care platform offering consumer test kits plus telehealth and pharmacy integrations. Closely matches Intrivo's test-to-treat model and integrated digital health infrastructure.
• Hims & Hers Health: Consumer digital health company offering telehealth, prescription delivery, and connected experiences across multiple conditions. Comparable D2C-plus-platform model and emphasis on delightful user experience.

Broad incumbents

• Teladoc Health: Large incumbent virtual care platform providing telehealth, chronic condition management, and RPM at scale. Overlaps with Intrivo's telehealth and connected device capabilities but operates across a much broader portfolio.
• Babylon Health: Global digital health platform offering AI-powered triage, telehealth, and population health services. Comparable as an integrated AI-driven virtual care platform, though at much larger enterprise scale.
• Doctor On Demand (Included Health): Integrated virtual care platform combining telehealth, behavioral health, and navigation for employers and health plans. Comparable enterprise-focused virtual care delivery, though at much larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/intrivo
• Facebookfacebook.com/intrivo
• LinkedInlinkedin.com/company/66917307
• Instagraminstagram.com/weareintrivo?igsh=MW1jbHlsOTZtZXg4cg==

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intrivo Diagnostics